Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Wave Life Sciences Ltd (NASDAQ: WVE) closed at $7.14 up 2.15% from its previous closing price of $6.99. In other words, the price has increased by $2.15 from its previous closing price. On the day, 2.6 million shares were traded. WVE stock price reached its highest trading level at $7.24 during the session, while it also had its lowest trading level at $6.93.
Ratios:
For a deeper understanding of Wave Life Sciences Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.51 and its Current Ratio is at 2.51. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In the most recent recommendation for this company, Wells Fargo on October 20, 2025, initiated with a Overweight rating and assigned the stock a target price of $18.
On August 04, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $19.
On July 28, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $24.Oppenheimer initiated its Outperform rating on July 28, 2025, with a $24 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 13 ’25 when Rawcliffe Adrian sold 16,115 shares for $6.79 per share. The transaction valued at 109,421 led to the insider holds 12,700 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 1,000 shares of WVE for $6,688 on Nov 13 ’25. The Director now owns 18,203,009 shares after completing the transaction at $6.69 per share. On Nov 13 ’25, another insider, ADRIAN RAWCLIFFE, who serves as the Director of the company, bought 16,115 shares for $6.96 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 1193677952 and an Enterprise Value of 1025105920. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.93 while its Price-to-Book (P/B) ratio in mrq is 9.19. Its current Enterprise Value per Revenue stands at 9.385 whereas that against EBITDA is -7.74.
Stock Price History:
The Beta on a monthly basis for WVE is -1.68, which has changed by -0.515928 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, WVE has reached a high of $15.72, while it has fallen to a 52-week low of $5.28. The 50-Day Moving Average of the stock is -4.18%, while the 200-Day Moving Average is calculated to be -8.36%.
Shares Statistics:
For the past three months, WVE has traded an average of 2.74M shares per day and 2093630 over the past ten days. A total of 160.29M shares are outstanding, with a floating share count of 134.97M. Insiders hold about 19.27% of the company’s shares, while institutions hold 82.40% stake in the company. Shares short for WVE as of 1763078400 were 15407887 with a Short Ratio of 5.63, compared to 1760486400 on 13141809. Therefore, it implies a Short% of Shares Outstanding of 15407887 and a Short% of Float of 12.2600004.
Earnings Estimates
Its stock is currently analyzed by 11.0 different market analysts. The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.27 and low estimates of -$0.35.
Analysts are recommending an EPS of between -$1.0 and -$1.27 for the fiscal current year, implying an average EPS of -$1.16. EPS for the following year is -$1.16, with 12.0 analysts recommending between -$0.65 and -$1.62.
Revenue Estimates
A total of 14 analysts believe the company’s revenue will be $17.63M this quarter.It ranges from a high estimate of $47M to a low estimate of $7.61M. As of. The current estimate, Wave Life Sciences Ltd’s year-ago sales were $83.75M
A total of 14 analysts have provided revenue estimates for WVE’s current fiscal year. The highest revenue estimate was $72.5M, while the lowest revenue estimate was $33.09M, resulting in an average revenue estimate of $43.96M. In the same quarter a year ago, actual revenue was $108.3M
